Stock Screener App

Gratuito -

Installare

Medical Instruments & Supplies

252.47

0.62% 1.55

Resmed Inc (RMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RMD Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Resmed Inc Borsa (RMD) Ultime notizie

Resmed Insider Sold Shares Worth $497,660, According to a Recent SEC Filing - MarketScreener

Insider Selling: ResMed (NYSE:RMD) Director Sells 2,000 Shares of Stock - MarketBeat

Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus

Resmed director Farrell sells $497k in shares By Investing.com - Investing.com India

Resmed director Farrell sells $497k in shares - Investing.com

SG Americas Securities LLC Acquires 47,758 Shares of ResMed Inc. $RMD - MarketBeat

Robeco Institutional Asset Management B.V. Sells 11,596 Shares of ResMed Inc. $RMD - MarketBeat

ResMed officer Brett Sandercock discloses planned sale of 1,000 shares under trading plan - MSN

How ResMed Inc. (Common Stock) (RMEA) stock correlates with oil marketsWeekly Trend Summary & Weekly Return Optimization Plans - ulpravda.ru

Will ResMed Inc. stock gain from lower inflationJuly 2025 Catalysts & Expert Curated Trade Setups - ulpravda.ru

Why ResMed Inc. (RME) stock is listed among top recommendations2025 Short Interest & Accurate Trade Setup Notifications - ulpravda.ru

EV Market: How ResMed Inc. (Common Stock) (RMEA) stock correlates with oil marketsPortfolio Return Report & Pattern Based Trade Signal System - ulpravda.ru

Michael Farrell Sells 4,991 Shares of ResMed (NYSE:RMD) Stock - MarketBeat

Resmed Sets January 29 Date to Unveil Q2 FY2026 Results - TipRanks

ResMed CEO Michael Farrell Plans Further Insider Share Sale Under Rule 144 - TipRanks

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 - The Manila Times

Dow Theory LettersResmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 - FinancialContent

Resmed Insider Sold Shares Worth $1,240,065, According to a Recent SEC Filing - MarketScreener

Will ResMed Inc. stock deliver stable dividendsJuly 2025 Action & Verified Short-Term Plans - ulpravda.ru

How ResMed Inc. (RME) stock performs during market turbulenceQuarterly Trade Summary & Daily Growth Stock Investment Tips - ulpravda.ru

Is ResMed Inc. (RME) stock protected from inflationEntry Point & AI Enhanced Trading Alerts - ulpravda.ru

ResMed Officer Plans Further Share Sale Under Rule 144 - MSN

Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance

An excellent week for ResMed Inc.'s (NYSE:RMD) institutional owners who own 69% as one-year returns inch higher - Yahoo Finance

Resmed Receives FDA Clearance for AI-Personalized CPAP Mask Settings - San Diego Business Journal

Is This the Right Time to Add Resmed Stock to Your Portfolio? - TradingView — Track All Markets

ResMed Director Peter Farrell Plans Additional Insider Share Sale Under Rule 144 - TipRanks

ResMed CFO Sells Small Block of Shares Under Pre-Arranged Trading Plan - TipRanks

Insider at company (NYSE: RMD) files Rule 144 to sell 2,000 shares - Stock Titan

RMD (RMD) insider Michael Farrell files to sell 4,991 common shares - Stock Titan

Will ResMed Inc. stock attract more institutional investorsVolume Analysis Techniques & Outperform With Our Smart Trading Calculator - ulpravda.ru

The Truth About ResMed Inc: Sleep Tech Darling or Overhyped Dinosaur? - AD HOC NEWS

ResMed stock in focus: sleep-tech leader tests investor conviction after choppy start to the year - AD HOC NEWS

EBIT per share of Resmed Inc. – OTC:RSMDF - TradingView — Track All Markets

Global Sleep Tech Devices Market Poised for Strong Growth at a CAGR of ~17% by 2032, Driven by Rising Sleep Disorder Prevalence | DelveInsight - GlobeNewswire Inc.

ResMed updates CDI and share structure for December 2025 - MSN

Asset Management One Co. Ltd. Raises Holdings in ResMed Inc. $RMD - MarketBeat

ResMed Updates CDI and Share Structure for December 2025 - TipRanks

Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus

ResMed (RMD) CFO discloses 1,000-share planned stock sale in Form 4 - Stock Titan

ResMed Executive Files Routine Rule 144 Notice for Small Share Sale - TipRanks

ResMed (NYSE:RMD) General Counsel Michael Rider Sells 50 Shares - MarketBeat

ResMed (RMD) Valuation Check As Investors Await Fiscal Q2 Earnings Update - Sahm

ResMed Inc (RMD) general counsel reports 50-share insider stock sale - Stock Titan

What you need to know ahead of ResMed's earnings release - MSN

ResMed Q2 2026 Earnings Preview: EPS Growth Forecast & Analyst Rating | BarchartNews and Statistics - IndexBox

ResMed Inc. $RMD Shares Sold by TriaGen Wealth Management LLC - MarketBeat

Railway Pension Investments Ltd Increases Position in ResMed Inc. $RMD - MarketBeat

What You Need to Know Ahead of ResMed's Earnings Release - Barchart.com

ResMed Inc. (RMD) Stock Analysis: Unveiling A 19.19% Potential Upside For Investors - DirectorsTalk Interviews

ResMed Inc.: How a Sleep-Tech Powerhouse Is Turning Data, Devices and Chronic Care Into a Platform P - AD HOC NEWS

Geopolitics Watch: Is ResMed Inc Common Stock RMEA stock overpriced at current multiplesWeekly Profit Summary & Weekly Return Optimization Plans - moha.gov.vn

ResMed Inc Reports Changes in CHESS Depositary Interests and Securities - MSN

ResMed Inc. stock rises Friday, outperforms market - MarketWatch

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 69% of the company - simplywall.st

RMD (ticker: RMD) insider Brett Sandercock files to sell 1,000 shares - Stock Titan

ResMed (RMD) insider plans Rule 144 sale of 50 common shares - Stock Titan

ResMed Inc. $RMD Shares Sold by Inspire Investing LLC - MarketBeat

Here's What ResMed's (NYSE:RMD) Strong Returns On Capital Mean - Yahoo Finance

ResMed Inc. Reports Changes in Beneficial Ownership - MSN

The Truth About ResMed Inc: Is This Sleep Tech Stock Quietly Going Viral? - AD HOC NEWS

ResMed (RMD) Product Pipeline Analysis Report 2025 – ResearchAndMarkets.com - The AI Journal

ResMed (RMD) Product Pipeline Analysis Report 2025ResearchAndMarkets.com - Bluefield Daily Telegraph

Is ResMed CDI (ASX:RMD) Still Shaping Value For Investors? - Kalkine Media

Ethic Inc. Raises Stock Holdings in ResMed Inc. $RMD - MarketBeat

About Us | Laser Focus WorldResMed (RMD) Product Pipeline Analysis Report 2025ResearchAndMarkets.com - FinancialContent

ALC

$80.13

0.61%

MDLN

$40.52

1.77%

WST

$275.52

0.11%

HOLX

$74.87

0.01%

COO

$83.45

0.38%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters